Analytik Jena After Nine Months with Growth in Operating Business

15-Aug-2011 - Germany

With sales growth of almost 7.0 % and an increase of nearly 6.0 % in operating earnings, Analytik Jena is now entering the final straight of the 2010/2011 financial year. After nine months the Group generated sales of EUR 63.6 m and operating income of EUR 3.4 m. This was announced by the manufacturer of analytical measuring technology, life science instruments and optoelectronics at the presentation of the quarterly and the 9-months-figures in Jena.

Sales Development and Segments

The Group’s growing positioning on global markets is reflected in the rise in international sales in the reporting period. In total, goods were exported for EUR 45.0 m (previous year: EUR 38.9 m). This corresponds to well over two thirds of total sales or an export rate of 70.6 % as against 65.3 % in the the previous year.

The core segment of Analytical Instrumentation again benefited from its strong market positioning in Asia and increased its sales as forecast. The division generated sales of EUR 40.1 m (previous year: EUR 35.9 m) or a sales increase of 11.9 %. In the Life Science segment the Group generated sales of EUR 20.0 m (previous year: EUR 20.3 m) and 1.5 % less income than in the same period of the previous year. This development is primarily due to the fact that the sales forecast were postponed to the fourth quarter of 2010/2011. The Optics division contributed EUR 3.5 m (previous year: EUR 3.4 m) to total consolidated sales after nine months.

Earnings

Up 5.9 % year-on-year, the Group’s operating earnings development was solid. EBIT therefore amounted to EUR 3.4 m after the first nine months (previous year: EUR 3.2 m) with an EBIT margin of 5.4 %. EBITDA rose by 6.4 % to EUR 6.2 m (previous year: EUR 5.9 m). After the financial result had benefited from the favorable currency situation for Analytik Jena in the wake of rising financial income in the previous year, developments in foreign currencies, particularly the Japanese yen and the USD, had a negative effect this year due to higher financial expenses combined with lower financial income as against the same period of the previous year. Furthermore, earnings were significantly influenced by the measurement of derivatives compared to the previous year.

In the reporting period, Analytik Jena achieved a total net profit of EUR 0.6 m (previous year: EUR 2.5 m), 76.9 % less than in the previous year. This is equal to earnings per share of EUR 0.09 (previous year: EUR 0.47).

Changes in Statement of Financial Position

The Group’s total assets fell slightly by 3.2 % from EUR 83.6 m (September 30, 2010) to EUR 80.9 m as of June 30, 2011. In the reporting period, Analytik Jena reported equity of EUR 39.6 m (September 30, 2010: EUR 39.0 m). This corresponds to an equity ratio of 48.9 % (September 30, 2010: 46.7 %).
The Group’s cash and cash equivalents amounted to EUR 3.4 m as of the end of the reporting period.

Human Resources

As of June 30, 2011, the Group employed 803 staff, including 36 trainees (previous year: 780 employees, including 44 trainees).

Outlook

Analytik Jena AG is retaining its forecasts for the 2010/2011 financial year and, in particular, is anticipating an increase in earnings in the fourth quarter, bringing it to its stated target for the year as a whole. The end of the financial year will be considerably influenced by the business recovery in Japan. All signals indicate that Analytik Jena on the basis of good incoming orders can significantly increase its sales as well. In the core business of Analytical Instrumentation the Company assumes a stable sales development. Specifically in the Life Science segment, the Company is forecasting a sound sales increase in the fourth quarter. The Optics consumer division will continue to recover until the end of the period.

"In light of the good sales and earnings development in the third quarter and on the basis of the continuing good incoming orders, we are assuming of achieving our demanding operating earnings target of EUR 4.5 m as of September 30, 2011", says Klaus Berka, CEO of Analytik Jena AG. "The biggest present risk for the Company is in currency effects. Regardless of this, we are predicting that the Company will enjoy a stable, positive performance overall in its last and, traditionally, strongest quarter. We are retaining our forecasts for the financial year."

Other news from the department business & finance

These products might interest you

qTOWER iris

qTOWER iris by Analytik Jena

Real-time PCR thermal cycler qTOWER iris

Feel Free to Explore!

real-time PCR thermocyclers
qTOWER³ auto

qTOWER³ auto by Analytik Jena

Real-time PCR - fully automated for maximum efficiency

Compact, reliable and cost-effective qPCR thermal cycler for high throughput

real-time PCR thermocyclers
CyBio FeliX

CyBio FeliX by Analytik Jena

Automation of Cellular Assays

Flexible Pipetting Platform for Fully Automated Single to Multichannel Liquid Handling

pipetting robots
Octet R2 / Octet R4 / Octet R8

Octet R2 / Octet R4 / Octet R8 by Sartorius

Full power on 2, 4 or 8 channels: Label-free and GxP-compliant analysis of molecular interactions

Innovative label-free real-time protein quantification, binding kinetics and rapid screenings

protein analyzers
Ampha X30

Ampha X30 by Amphasys

Ampha X30 Single-Cell Analyzer: for the fast and accurate cell analysis

Efficient cell analysis of viability, count and cell status – without dyes, markers, and incubation

cell analyzers
Stopped Flow Systeme

Stopped Flow Systeme by Bio-Logic Science Instruments

50 µl of sample is all you need for a series of stopped-flow experiment

A unique micro volume stopped-flow solution for the most demanding applications

Octet SF3

Octet SF3 by Sartorius

Surface Plasmon Resonance (SPR) using Single Dynamic Injections for Kinetics and Affinities

Curvature is Key - Adding a ‘Third Dimension’ to the Binding Curve

Octet RH16 and RH96

Octet RH16 and RH96 by Sartorius

Efficient protein analysis for process optimisation and manufacturing control in high-throughput

Label-free protein quantification and characterization of protein-protein interactions

protein analyzers
Thermo Scientific Gallery Enzyme Master Enzyme Analyzer

Thermo Scientific Gallery Enzyme Master Enzyme Analyzer by Thermo Fisher Scientific

Efficiently manage enzyme assays and measuring conditions for consistent and reliable performance

Automate enzyme activity, enzyme assay and enzyme kinetics - Measure up to 350 samples per hour

Discrete Analyser
Amersham ImageQuant 800

Amersham ImageQuant 800 by Cytiva

Documenting gels and blots made easy thanks to highly sensitive CCD imaging device

The Ideal Solution for Chemiluminescence, Fluorescence and Colorimetric Imaging

gel documentation systems
Loading...

More news from our other portals

So close that even
molecules turn red...